Literature DB >> 28906302

Chemotherapy Extravasation Management: 21-Year Experience.

Maria Giuseppina Onesti1, Sara Carella, Paolo Fioramonti, Nicolò Scuderi.   

Abstract

Chemotherapy extravasation may result in serious damage to patients, with irreversible local injures and disability. Evidence-based standardization on extravasation management is lacking and many institutions do not practice adequate procedures to prevent the severer damages. Our aim was to explore the prevention and treatment of extravasation injuries, proposing a standard therapeutic protocol together with a review of the literature. From January 1994 to December 2015, 545 cases were reviewed (age range, 5-87 years; 282 men and 263 women). Our therapeutic protocol consisted of local infiltration of saline solution and topical occlusive applications of corticosteroids. The infiltrations were administrated 3 to 6 times a week depending on damage severity. Our protocol allowed us to prevent ulceration in 373 cases. Only 27 patients required surgery (escarectomy, skin graft, regional, and free flap). Numerous treatments have been proposed in literature. The antidotes have been discussed controversially and are not considered standard methods for treatment, especially when polychemotherapy is administrated and the identification of the responsible drug is not possible. We proposed the use of saline solution injection to dilute rapidly the drug, thus reducing its local toxic effects. This method is easy to use and always reproducible even when the drug is not known or when it is administrated in combination with other drugs. It is possible to perform it in ambulatory regimen, and, overall, it represents a standard method.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28906302     DOI: 10.1097/SAP.0000000000001248

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  4 in total

1.  Determination of Extravasation Effects of Nal-Iri and Trabectedin and Evaluation of Treatment Options for Trabectedin Extravasation in a Preclinical Animal Model.

Authors:  Omar Keritam; Viktoria Juhasz; Christian Schöfer; Christiane Thallinger; Marie-Bernadette Aretin; Gernot Schabbauer; Johannes Breuss; Matthias Unseld; Pavel Uhrin
Journal:  Front Pharmacol       Date:  2022-06-03       Impact factor: 5.988

2.  Tissue distribution of epirubicin after severe extravasation in humans.

Authors:  Jakob Nedomansky; Werner Haslik; Ursula Pluschnig; Christoph Kornauth; Christine Deutschmann; Stefan Hacker; Günther G Steger; Rupert Bartsch; Robert M Mader
Journal:  Cancer Chemother Pharmacol       Date:  2021-04-27       Impact factor: 3.333

3.  Changes in the subcutaneous tissue of catheterization site from the precatheterization state to the onset of anticancer drug-induced induration: A case report.

Authors:  Mari Abe-Doi; Ryoko Murayama; Chieko Komiyama; Hiromi Sanada
Journal:  Clin Case Rep       Date:  2020-12-02

4.  Surgical intervention for paediatric infusion-related extravasation injury: a systematic review.

Authors:  Max Little; Sophie Dupré; Justin Conrad Rosen Wormald; Matthew Gardiner; Chris Gale; Abhilash Jain
Journal:  BMJ Open       Date:  2020-08-06       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.